Global In-Vivo Toxicology Market is Estimated to Value Over USD 6.5 Billion by 2026 End

  • 07 Oct 2019

Global In-Vivo Toxicology Market is estimated to value over USD 6.5 billion by 2026 end and register a CAGR of over 5.9% during the forecast period 2019 to 2026.

The global in-vivo toxicology market growth is driven by factors such as the increasing research and development expenditure for detecting early stage toxicity during the process of developing drugs, the technological advancements and the opposition to animal testing.

The organ toxicity is predicted to proliferate with a high value of CAGR over the forecast period. The segment growth can be credited to factors, for instance, the rising emphasis on consumer-product safety and drug safety coupled with the requirement for potential screening of targets of drugs during the early drug development stage. Cell cultures are predicted to hold the largest global in-vivo toxicology market share in 2017. This segment dominance can be due to it being the most prioritised method for being able to mimic in-vivo conditions and testing toxicity.

The Asia Pacific market region is projected to record the highest augmentation over the forecast period. The advent of CROs in order to outsource projects related to the toxicology research, growing pipeline of pharmaceutical drugs and increasing awareness amongst consumers regarding the safety of products are some important factors steering the augmentation of the market in the region.


Global In-Vivo Toxicology Market Segmentation:

By Product

  • Consumables

- Reagents & Kits

- Animal Models

~ Mice Models

~ Rat Models

~ Other Animal Models

  • Instruments

By Testing Type

  • Chronic Toxicity Testing
  • Sub-Chronic Toxicity Testing
  • Sub-Acute Toxicity Testing
  • Acute Toxicity Testing

By Toxicity Endpoint

  • Immunotoxicity
  • Systemic Toxicity
  • Carcinogenicity
  • Genotoxicity
  • Other Toxicity Endpoints

By Testing Facility

  • Outsourced Testing Facilities
  • In-House Testing Facilities

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa


FutureWise Key Takeaways:

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth


Objectives of the Study:

  • To provide with an exhaustive analysis on the global in-vivo toxicology market by product, by testing point, by toxicity endpoint, by testing facility and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East & Africa
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • Profiling of companies to evaluate their market shares, strategies, financials and core competencies


Get unlimited analyst support and customise this study further to your requirements, contact